---
schema_version: "secwatch.filing_event.v1"
accession: "0001682852-22-000033"
form_type: "8-K"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2022-05-24T23:59:59+00:00"
generated_at: "2026-06-25T07:42:40.217103+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Moderna CEO Bancel amends 10b5-1 plan to exercise 4.6M options; expects to donate $355M proceeds

## Summary
- CEO Bancel amended 10b5-1 plan to exercise 4,587,155 shares at $0.99/share (option from 2013, expiring Aug 2023).
- Exercise schedule: 40,000 shares each Wednesday and Thursday starting May 25, 2022, until fully exercised.
- After-tax proceeds (~$355M at ~$140/sh) to be donated to charity; ~$280M in taxes paid.
- Bancel's family entity OCHA LLC continues selling 10,000 shares each Thursday under separate 10b5-1 plan through end of 2022.
- Bancel terminated prior 10b5-1 plans for gifts/sales in March 2022.

## SEC filing metadata
- accession: 0001682852-22-000033
- form_type: 8-K
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2022-05-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000168285222000033/0001682852-22-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000168285222000033/mrna-20220524.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001682852-22-000033
- JSON: https://secwatch.observer/filing/0001682852-22-000033.json
- Plain text: https://secwatch.observer/filing/0001682852-22-000033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.